Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
16.46
-0.46 (-2.72%)
At close: Apr 28, 2026, 4:00 PM EDT
16.42
-0.04 (-0.24%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Pharming Group Employees
Pharming Group had 407 employees as of December 31, 2025. The number of employees increased by 3 or 0.74% compared to the previous year.
Employees
407
Change (1Y)
3
Growth (1Y)
0.74%
Revenue / Employee
$924,162
Profits / Employee
$7,005
Market Cap
1.17B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| AbCellera Biologics | 562 |
| UroGen Pharma | 291 |
| uniQure | 221 |
| EyePoint | 214 |
| Zenas BioPharma | 167 |
| MoonLake Immunotherapeutics | 130 |
| Septerna | 130 |
PHAR News
- 5 days ago - Pharming Group to report first quarter 2026 financial results and provide business update on May 7 - GlobeNewsWire
- 12 days ago - Pharming Group announces the 2026 Annual General Meeting of Shareholders - GlobeNewsWire
- 15 days ago - Pharming Group Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 21 days ago - Pharming Group to participate in April investor conferences - GlobeNewsWire
- 26 days ago - Pharming Group announces the filing of its 2025 Annual Report and Form 20-F - GlobeNewsWire
- 4 weeks ago - Pharming Group receives positive CHMP opinion for Joenja® (leniolisib) for the treatment of APDS in adult and pediatric patients 12 years and older - GlobeNewsWire
- 5 weeks ago - Pharming Group's Leniolisib Gets Japan Approval To Treat APDS Patients Aged 4 Years And Older - Nasdaq
- 5 weeks ago - Pharming Group announces approval of Joenja® (leniolisib) in Japan for the treatment of APDS in patients aged 4 years and older - GlobeNewsWire